Lyell Immunopharma, Inc. (LYEL)

23.80 +0.47 (+2.01%) USD  |  NASDAQ  |  Mar 04, 16:00
23.88 +0.08 (+0.34%) After-Hours: 20:00
More

Lyell Immunopharma Earnings Loss from Eq. Investments (Quarterly)

Earnings Loss from Eq. Investments (Quarterly) Chart

View Earnings Loss from Eq. Investments (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Earnings Loss from Eq. Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Earnings Loss from Eq. Investments (Quarterly) Range, Past 5 Years

View Earnings Loss from Eq. Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Earnings Loss from Eq. Investments (Quarterly) Benchmarks

View Earnings Loss from Eq. Investments (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Nektar Therapeutics Upgrade
GT Biopharma, Inc. --
Regeneron Pharmaceuticals, Inc. --
Vertex Pharmaceuticals, Inc. --